We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Jack in the Box
JACK
$312M
| $3.67M | 0.01% |
53,769
-470
| -0.9% | -$28.3K |
|
|
POLY
927
DELISTED
Plantronics, Inc.
POLY
| $3.66M | 0.01% |
76,694
+130
| +0.2% | +$6.22K |
|
|
FNFG
928
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $3.66M | 0.01% |
439,877
-8,450
| -2% | -$73.2K |
|
929
Bank OZK
OZK
$5.6B
| $3.66M | 0.01% |
116,084
-42,940
| -27% | -$1.39M |
|
930
Valley National Bancorp
VLY
$7.9B
| $3.65M | 0.01% |
377,159
+1,300
| +0.3% | +$12.8K |
|
931
Watsco Inc
WSO
$12.7B
| $3.64M | 0.01% |
42,269
+995
| +2% | +$92K |
|
|
DYN
932
DELISTED
Dynegy, Inc.
DYN
| $3.64M | 0.01% |
126,129
-4,240
| -3% | -$126K |
|
933
Viavi Solutions
VIAV
$9.12B
| $3.64M | 0.01% |
499,727
+3,902
| +0.8% | +$26.8K |
|
934
Encompass Health
EHC
$11B
| $3.63M | 0.01% |
123,838
-4,067
| -3% | -$124K |
|
935
Middleby
MIDD
$6.04B
| $3.63M | 0.01% |
41,206
-15,125
| -27% | -$1.25M |
|
936
Chemed
CHE
$7.07B
| $3.62M | 0.01% |
35,196
-2,939
| -8% | -$298K |
|
937
Cousins Properties
CUZ
$5.19B
| $3.62M | 0.01% |
107,228
+6,802
| +7% | +$242K |
|
|
CST
938
DELISTED
CST Brands, Inc.
CST
| $3.62M | 0.01% |
100,552
+1,380
| +1% | +$47.7K |
|
|
TQNT
939
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $3.6M | 0.01% |
189,051
+250
| +0.1% | +$4.64K |
|
|
IDTI
940
DELISTED
Integrated Device Technology I
IDTI
| $3.6M | 0.01% |
225,630
+6,725
| +3% | +$104K |
|
941
MarketAxess Holdings
MKTX
$5.71B
| $3.6M | 0.01% |
58,136
+13,040
| +29% | +$735K |
|
|
FCS
942
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $3.58M | 0.01% |
230,721
+50
| +0% | +$807 |
|
943
First Horizon
FHN
$12.2B
| $3.57M | 0.01% |
290,962
+30
| +0% | +$360 |
|
944
Graham Holdings Company
GHC
$5.1B
| $3.57M | 0.01% |
8,450
-1,996
| -19% | -$858K |
|
945
Novartis
NVS
$297B
| $3.56M | 0.01% |
42,179
| – | – |
|
946
UMB Financial
UMBF
$11.1B
| $3.55M | 0.01% |
65,118
+590
| +0.9% | +$34.1K |
|
947
Pebblebrook Hotel Trust
PEB
$2.15B
| $3.55M | 0.01% |
94,954
-320
| -0.3% | -$12.1K |
|
948
Wintrust Financial
WTFC
$10.8B
| $3.54M | 0.01% |
79,354
+1,330
| +2% | +$61.6K |
|
949
Dana Inc
DAN
$2.9B
| $3.53M | 0.01% |
184,245
-2,470
| -1% | -$56.1K |
|
|
ROC
950
DELISTED
ROCKWOOD HLDGS INC
ROC
| $3.52M | 0.01% |
46,111
-1,327
| -3% | -$106K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.